Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANCE pilot feasibility trial of Dengzhan Shengmai capsules added to aspirin for non-disabling cerebrovascular events
ChiCTR2000039184Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Dengzhan Shengmai and aspirin in transient ischaemic attack (TIA) and ischemic stroke (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: New stroke event. Started Dec 2019; status: recruiting.
02
Drugs
Dengzhan Shengmaiaspirin
03
Conditions
transient ischaemic attack (TIA)ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000039184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039184.